Cytokinetics Inc

Cytokinetics Inc

CYTK

Market Cap$3.7B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cytokinetics IncCytokinetics Inc-6-231%--3.2
$61.00

Target Price by Analysts

90.1% upsideCytokinetics Target Price DetailsTarget Price
$-11.38

Current Fair Value

135.5% downside

Overvalued by 135.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.70 Billion
Enterprise Value$4.47 Billion
Dividend Yield$0 (0%)
Earnings per Share$-5.26
Beta0.81
Outstanding Shares118,496,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-5.97
PEG-31.49
Price to Sales-
Price to Book Ratio-10.69
Enterprise Value to Revenue232.82
Enterprise Value to EBIT-8.37
Enterprise Value to Net Income-8
Total Debt to Enterprise0.19
Debt to Equity-3.17

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Cytokinetics Inc

CEO: Robert Blum